女性艾滋病患者的抗反转录病毒治疗与人类免疫缺陷病毒母婴阻断

蔡仁田1; 卢洪洲1; 2; 3

PDF(560 KB)

微生物与感染 ›› 2014, Vol. 9 ›› Issue (3) : 191-196.

综述

女性艾滋病患者的抗反转录病毒治疗与人类免疫缺陷病毒母婴阻断

蔡仁田¹，卢洪洲^1,2,3

作者信息 +

Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome

CAI Ren-Tian¹，LU Hong-Zhou^1,2,3

Author information +

文章历史 +

摘要

自从对感染人类免疫缺陷病毒（HIV）的妊娠妇女实施抗反转录病毒治疗（ART）以预防垂直传播以来，HIV母婴阻断成功率明显上升。而部分抗病毒药物，如依非韦伦和替诺福韦，也逐渐被证明在妊娠期妇女中使用对胎儿是安全的，这增加了HIV母婴阻断药物的选择范围。

Abstract

Since antiretroviral therapy was implemented in pregnant women infected with human immunodeficiency virus (HIV), the success rate of prevention of mother-to-child transmission (PMTCT) of HIV has been increased significantly. And some antiviral drugs, such as efavirenz and tenofovir, have gradually been proven to be safe for pregnant women and fetus. The range of options for PMTCT drugs is increased.

导出引用

蔡仁田1，卢洪洲1,2,3. 女性艾滋病患者的抗反转录病毒治疗与人类免疫缺陷病毒母婴阻断[J]. 微生物与感染. 2014, 9(3): 191-196

CAI Ren-Tian1，LU Hong-Zhou1,2,3. Antiretroviral treatment and prevention of mother-to-child transmission of human immunodeficiency virus in women with acquired immunodeficiency syndrome[J]. Journal of Microbes and Infections. 2014, 9(3): 191-196